{"id":"W3001622551","doi":"10.1016/j.ejca.2019.12.029","title":"ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hospital for Sick Children","funders":"Cancer Research UK; CHILDREN with CANCER UK; Action Medical Research","keywords":"Medicine; Clinical trial; Agency (philosophy); Intensive care medicine; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02298916,0.001168321,0.0009822311,0.001995027,0.001058827,0.004466338,0.00235795,0.01256564,0.02383427],"category_scores_gemma":[0.01994313,0.0005881354,0.001966946,0.001227822,0.001165966,0.00211353,0.00275115,0.007978086,0.007902673],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003037467,"about_ca_system_score_gemma":0.0303991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004584506,"about_ca_topic_score_gemma":0.006407202,"domain_scores_codex":[0.990238,0.003273546,0.0006392563,0.0004518109,0.004006396,0.001391134],"domain_scores_gemma":[0.9761539,0.004010122,0.00428773,0.0007641147,0.008769751,0.006014319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001020021,0.000639677,0.001365337,0.001188047,0.0001224472,0.0008933728,0.0001267686,0.0008086105,0.00833276,0.0181341,0.7495981,0.2177708],"study_design_scores_gemma":[0.0003086077,0.0003913168,0.001047256,0.0005058933,0.0000430721,0.0004206212,0.00002942005,0.0001988711,0.001626706,0.001312641,0.9940972,0.00001845574],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.01178887,0.09262154,0.01690804,0.5646522,0.03204423,0.003511569,0.01682512,0.002091436,0.259557],"genre_scores_gemma":[0.1041929,0.106983,0.07295149,0.3717729,0.01925415,0.002937039,0.0210531,0.00138649,0.299469],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02383427,"threshold_uncertainty_score":0.1215797,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04738878254134485,"score_gpt":0.2875636237656424,"score_spread":0.2401748412242975,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}